Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro

Table 3. Number of DENV-1 foci by favipiravir at various concentrations.

Favipiravir concentration (μg/mL)	Number of foci treatment (FFU ± SD)*
10	8.67 ± 2.52^a
5	33.00 ± 3.61^a
2.5	58.67 ± 7.57^a
1.25	64.33 ± 6.66^a
0.625	78.00 ± 8.19^a
0.3125	86.67 ± 1.53^a
DMSO 0.1% Control	118.33 ± 8.07

* Performed by focus forming assay (immunostaining); a :p value ≤ 0.01. The mean number was counted from triplicate experiments.